Off-the-Shelf Circular mRNA Vaccine Exploiting Non-Conventional Tumour Antigens to Improve Immunotherapy of Mismatch Repair-Proficient Colorectal Cancer

Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?

D Bhatia, R Dolcetti, R Mazzieri

2025-01-01

In the last two decades, novel and promising cell-based therapies have populated the treatment landscape for haematological tumors..